Company
Is Coherus Biosciences Inc (NASDAQ: CHRS) Still A Buy After plugging 0.50% Last Week?
During the last session, Coherus Biosciences Inc (NASDAQ:CHRS)’s traded shares were 0.75 million, with the beta value of the company hitting 0.89. At the end